Erratum: Okuwaki K, Kida M, Mikami T, Yamauchi H, Imaizumi H, Miyazawa S, Iwai T, Takezawa M, Saegusa M, Watanabe M and Koizumi W. Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes. Cancer. 2013;119:4094-102.

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|8|1283-1285

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.8, 2014-04, pp. : 1283-1285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus Cardiovasc

By Manfredi Samantha   Calvi Debora   del Fiandra Martina   Botto Nicoletta   Biagini Andrea   Andreassi Maria Grazia  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 29-34

Future Medicine

Access to resources Recommend Favorite

''Sterile Filtration; A Practical Approach'' M.W. Jornitz, T.H. Meltzer (Editors), Marcel Dekker, New York, Basel; 2001, 623 pages, US$ 195; ISBN 0-8247-0282-4

By Groves M.J.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 52, Iss. 3, 2001-11 ,pp. : 369-369

Elsevier

Access to resources Recommend Favorite

Erratum: Lee Y, Lee GK, Lee YS, Zhang W, Hwang JA, Nam BH, Kim SH, Kim JH, Yun T, Han JY, Kim HT and Lee JS. Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations. Cancer. 2014;120:2090-8.

By  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 161-161

Blackwell Publishing

Access to resources Recommend Favorite

Muscarinic M1 receptor agonists and M2 receptor antagonists as therapeutic targets in Alzheimer’s disease

By Sheardown Malcolm J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

The (S)-(+)-enantiomer of dimethindene: a novel M 2 -selective muscarinic receptor antagonist

By Pfaff O.   Hildebrandt C.   Waelbroeck M.   Xue H.   Moser U.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 229-240

Elsevier

Access to resources Recommend Favorite